Global Bipolar Disorder Market Analysis, Drivers, Restraints, Opportunities, Threats, Trends, Applications, and Growth Forecast to 2027

MarketResearch.biz delivers in-depth insights on the global bipolar disorder market in its upcoming report titled, “Global Bipolar Disorder Market Analysis, Drivers, Restraints, Opportunities, Threats, Trends, Applications, and Growth Forecast to 2027”. The global bipolar disorder market is estimated to register a CAGR of X.X% in terms of value during the forecast period 2018–2027. The report offers in-depth insights, revenue details, and other vital information regarding the global bipolar disorder market, and the various trends, drivers, restraints, opportunities, and threats in the target market till 2027. The report offers insightful and detailed information regarding the various key players operating in the global bipolar disorder market, their financials, supply chain trends, technological innovations, key developments, apart from future strategies, acquisitions & mergers, and market footprint. The global bipolar disorder market report has been segmented on the basis of type, drug class, mechanism of action, and region.

Request Covid - 19 Impact

Bipolar Disorder, also known as manic depression, is a brain disorder that causes unusual changes in person’s mood, ability to function, and energy levels. People suffering from bipolar disorders have extreme and intense emotional states that occur at different times, called mood episodes. People with bipolar disorder have instants in which they feel very happy and energized and sometimes feel very sad, sluggish, and hopeless.

Technological advancements that facilitate accurate detection of patient’s mood and mental state and growing government initiatives for creating awareness about bipolar disorders are key factors driving growth of the global bipolar disorder market. In addition, increasing incidence of bipolar disorders across the globe is a major factor expected to fuel growth to the global bipolar disorder market over forecast period.

However, many of the drugs used in treatment of bipolar disorders have associated side effects such as blurred vision, damage to the liver, thyroid disorders, etc. This is a key factor restraining growth of the global bipolar disorder market. Additionally, stringent government regulations on drug manufacturing and misdiagnosis of bipolar disorder are major factors expected to hamper growth of the global bipolar diagnostics market over the forecast period.

North America is a dominant player in the global bipolar disorder market and accounts for highest market share in terms of revenue as compared to that of markets in other regions. This is attributed to increasing government initiatives for creating awareness about bipolar disorders and availability of treatment options in the region. Europe accounts for the second highest revenue share contribution to the global bipolar disorder market. The market in Asia Pacific is projected to have the fastest growth in terms of CAGR, owing to increasing awareness about mental illnesses in the region.

Global Bipolar Disorder Market Segmentation:

Global bipolar disorder market segmentation by type:

• Bipolar I disorder
• Bipolar II disorder
• Cyclothymic disorder

Global bipolar disorder market segmentation by drug class:

• Mood stabilizer
• Anticonvulsant
• Antipsychotic drugs
• Antidepressant drugs
• Antianxiety drugs

Global bipolar disorder market segmentation by mechanism of action:

• Selective serotonin reuptake inhibitor
• Serotonin norepinephrine reuptake inhibitor
• Tricyclic antidepressants
• Monoamine oxidase inhibitors
• Benzodiazepines
• Beta blockers
• Others

Global bipolar disorder market segmentation by region:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa